Home > Drug Search >
  • company_query: Beijing Sihuan Pharmaceutical
  •   > 
Drug Filter
Category:
chemistry (24) biology (41)
Status:
Approved (4) NDA Filing (3) BLA Filing (1) Phase Ⅲ (6) Phase Ⅱ (21) Phase Ⅰ (28) IND Filing (2)
Clinical Stage:
Pending (8) Active (45) Discontinued (8)
Bio-Type:
Gene therapy (4) Vaccine (20) Recombinant enzyme (2) Recombinant coagulation factor (3) Recombinant cytokines (1) Whole antibody (11)
Indication:
Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (1) Bladder cancer (1) Breast cancer (5) Candidiasis (1) Chronic lymphocytic leukemia (CLL) (1) ischaemic heart disorder (1) Herpes simplex virus (1) Diarrhea (1) Gastric cancer (1) Gaucher's disease (GD) (1) Glaucoma (1) Dyskinesia (2) HIV infection (8) Hyperbilirubinemia (1) Leukemia (1) Melanoma (1) Metastatic breast cancer (1) Motion sickness (1) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (1) Ovarian cancer (3) Pancreatic cancer (2) Peripheral arterial disease (PAD) (1) Primary hypercholesterolemia (1) Prostate cancer (1) Rheumatoid arthritis (RA) (4) Schizophrenia (2) Solid tumours (3) Systemic lupus erythematosus (1) Type 2 diabetes (3) Head and neck cancer (1) Influenza A virus infections (2) Inborn genetic disorders (1) Colorectal cancer (2) Ankylosing Spondylitis (AS) (1) Colon cancer (1) Neuroblastoma (1) Bone metastases from solid tumors (1) HER2-positive metastatic breast cancer (1) Malaria (1) Hemophilia A (2) Hemophilia B (1) Immune-inflammatory diseases (1) Autoimmune diseases (3) Esophagus cancer (1) Clostridial infection (1) Plaque psoriasis (1) Hearing loss (1) Diffuse large B cell lymphoma (1) Stem cell mobilization (1) Dengue fever (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 4 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top